Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/aging.203229 http://scihub22266oqcxt.onion/10.18632/aging.203229 34228637!8312471!34228637     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\34228637.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Aging+(Albany+NY) 2021 ; 13 (13): 16904-16921 Nephropedia Template TP {{tp|p=34228637|t=2021. Prognostic and immunological value of ATP6AP1 in breast cancer: implications for SARS-CoV-2 |pdf=|usr=}}{{34228637}} gab.com Text Prognostic and immunological value of ATP6AP1 in breast cancer: implications for SARS-CoV-2 JO: Aging (Albany NY) http://www.kidney.de/pget.php?&tw=1&pmid=34228637 #FOAvip Abnormal ATPase H+ Transporting Accessory Protein 1 (ATP6AP1) expression may promote carcinogenesis. We investigated the association of ATP6AP1 with breast cancer (BC) and COVID-19. The Oncomine, Gene Expression Profiling Interactive Analysis, Human Protein Atlas and Kaplan-Meier plotter databases were used to evaluate the expression and prognostic value of ATP6AP1 in BC. ATP6AP1 was upregulated in BC tissues, and higher ATP6AP1 expression was associated with poorer outcomes. Data from the Tumor Immune Estimation Resource, Tumor-Immune System Interaction Database and Kaplan-Meier plotter indicated that ATP6AP1 expression correlated with immune infiltration, and that its prognostic effects in BC depended on tumor-infiltrating immune cell subtype levels. Multiple databases were used to evaluate the association of ATP6AP1 with clinicopathological factors, assess the mutation and methylation of ATP6AP1, and analyze gene co-expression and enrichment. The ATP6AP1 promoter was hypomethylated in BC tissues and differentially methylated between different disease stages and subtypes. Data from the Gene Expression Omnibus indicated that ATP6AP1 levels in certain cell types were reduced after SARS-CoV-2 infections. Ultimately, higher ATP6AP1 expression was associated with a poorer prognosis and with higher or lower infiltration of particular immune cells in BC. BC patients may be particularly susceptible to SARS-CoV-2 infections, which may alter their prognoses. Twit Text FOAVip Prognostic and immunological value of ATP6AP1 in breast cancer: implications for SARS-CoV-2 ????Aging (Albany NY) http://www.kidney.de/pget.php?&tw=1&pmid=34228637 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34228637 #FOAvip English Wikipedia <ref>{{Cite pmid|34228637}}</ref> Prognostic and immunological value of ATP6AP1 in breast cancer: implications for SARS-CoV-2 #MMPMID34228637 Wang J; Liu Y; Zhang S Aging (Albany NY) 2021[Jul]; 13 (13): 16904-16921 PMID34228637show ga Abnormal ATPase H+ Transporting Accessory Protein 1 (ATP6AP1) expression may promote carcinogenesis. We investigated the association of ATP6AP1 with breast cancer (BC) and COVID-19. The Oncomine, Gene Expression Profiling Interactive Analysis, Human Protein Atlas and Kaplan-Meier plotter databases were used to evaluate the expression and prognostic value of ATP6AP1 in BC. ATP6AP1 was upregulated in BC tissues, and higher ATP6AP1 expression was associated with poorer outcomes. Data from the Tumor Immune Estimation Resource, Tumor-Immune System Interaction Database and Kaplan-Meier plotter indicated that ATP6AP1 expression correlated with immune infiltration, and that its prognostic effects in BC depended on tumor-infiltrating immune cell subtype levels. Multiple databases were used to evaluate the association of ATP6AP1 with clinicopathological factors, assess the mutation and methylation of ATP6AP1, and analyze gene co-expression and enrichment. The ATP6AP1 promoter was hypomethylated in BC tissues and differentially methylated between different disease stages and subtypes. Data from the Gene Expression Omnibus indicated that ATP6AP1 levels in certain cell types were reduced after SARS-CoV-2 infections. Ultimately, higher ATP6AP1 expression was associated with a poorer prognosis and with higher or lower infiltration of particular immune cells in BC. BC patients may be particularly susceptible to SARS-CoV-2 infections, which may alter their prognoses. |Biomarkers, Tumor/*analysis[MESH] |Breast Neoplasms/diagnosis/*genetics/immunology[MESH] |COVID-19/diagnostic imaging/*genetics/immunology[MESH] |DNA Methylation[MESH] |Female[MESH] |Gene Expression Regulation, Enzymologic[MESH] |Gene Expression Regulation, Neoplastic[MESH] |Humans[MESH] |Kaplan-Meier Estimate[MESH] |Mutation/genetics[MESH] |Predictive Value of Tests[MESH] |Prognosis[MESH] |Survival Analysis[MESH] |Treatment Outcome[MESH]Prognostic and immunological value of ATP6AP1 in breast cancer: implic(epmc).pdf DeepDyve Pubget Overpricing